These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15241641)

  • 41. Sodium nitrite as a therapeutic agent for central nervous system diseases.
    Pluta RM; Oldfield EH
    Surg Neurol; 2006 Jul; 66(1):5-7; discussion 8-10. PubMed ID: 16793425
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pontine stroke due to vasospasm secondary to perimesencephalic subarachnoid hemorrhage].
    Mayor S; Erro ME; Zazpe I; Gállego J
    Neurologia; 2008 May; 23(4):256-8. PubMed ID: 18516747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraarterial infusion therapy for cerebral vasospasm: promising but preliminary.
    Nozaki K
    World Neurosurg; 2012; 78(3-4):223-5. PubMed ID: 22819612
    [No Abstract]   [Full Text] [Related]  

  • 44. Just say NO to vasospasm.
    Mayberg MR
    J Neurosurg; 2011 Dec; 115(6):1210-2; discussion 1212. PubMed ID: 21888478
    [No Abstract]   [Full Text] [Related]  

  • 45. Classification of endothelin receptors and antagonists in clinical development.
    Davenport AP; Battistini B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():1S-3S. PubMed ID: 12193042
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effects, side effects and interactions. Endothelin and endothelin receptor antagonists].
    Dahse AJ; Nieber K
    Pharm Unserer Zeit; 2010 Nov; 39(6):436-41. PubMed ID: 20967931
    [No Abstract]   [Full Text] [Related]  

  • 47. Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm?
    Cosentino F; Katusić ZS
    Stroke; 1994 Apr; 25(4):904-8. PubMed ID: 8160238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is There a Role of Intrathecal Calcium Channel Blockers in Treating Cerebral Vasospasm?
    Sadan O; Samuels OB
    World Neurosurg; 2021 Oct; 154():169-171. PubMed ID: 34583472
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of endothelin-1 as predictor of the symptomatic vasospasm in acute stage of subarachnoid haemorrhage.
    Kim JM; Bak KH; Kim CH; Park IK; Oh SJ; Choi HK
    Acta Neurochir Suppl; 2001; 77():77-9. PubMed ID: 11563314
    [No Abstract]   [Full Text] [Related]  

  • 50. Prognostic factors and targets for intervention after subarachnoid hemorrhage.
    Redekop GJ
    Stroke; 2007 Aug; 38(8):2217-8. PubMed ID: 17569870
    [No Abstract]   [Full Text] [Related]  

  • 51. Endothelin antagonists for chronic heart failure: do they have a role?
    Cowburn PJ; Cleland JG
    Eur Heart J; 2001 Oct; 22(19):1772-84. PubMed ID: 11549299
    [No Abstract]   [Full Text] [Related]  

  • 52. Cellular Microparticles in Subarachnoid Hemorrhage.
    Boettinger S; Lackner P
    Transl Stroke Res; 2015 Oct; 6(5):342-4. PubMed ID: 26099349
    [No Abstract]   [Full Text] [Related]  

  • 53. [The use of endothelin-1 receptor antagonists in cardiovascular diseases].
    Modesti PA
    G Ital Cardiol; 1999 Dec; 29(12):1572-8. PubMed ID: 10687125
    [No Abstract]   [Full Text] [Related]  

  • 54. [Linkage of gene expression with cerebral vasospasm].
    Ono S; Date I; Ohmoto T
    No Shinkei Geka; 2001 Jul; 29(7):589-602. PubMed ID: 11517500
    [No Abstract]   [Full Text] [Related]  

  • 55. Etomidate, transfusion, and vasospasm.
    Drummond JC; Cole DJ; Patel PM
    J Neurosurg; 2005 Mar; 102(3):583-4; author reply 585-6. PubMed ID: 15796403
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular pharmacology. Endothelin versatility.
    Goto K; Warner TD
    Nature; 1995 Jun; 375(6532):539-40. PubMed ID: 7791868
    [No Abstract]   [Full Text] [Related]  

  • 57. Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: a clinical study and literature review.
    Kraus GE; Bucholz RD; Yoon KW; Knuepfer MM; Smith KR
    Surg Neurol; 1991 Jan; 35(1):20-9. PubMed ID: 1983878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasospasm.
    Meyer FB
    J Neurosurg; 2007 May; 106(5):879-80; discussion 880. PubMed ID: 17542533
    [No Abstract]   [Full Text] [Related]  

  • 59. Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): the role of calcium antagonists.
    Dodick DW
    Cephalalgia; 2003 Apr; 23(3):163-5. PubMed ID: 12662181
    [No Abstract]   [Full Text] [Related]  

  • 60. Using receptor antagonists in binding studies to characterize a mammalian endothelin receptor.
    Wu-Wong JR
    Methods Mol Biol; 2002; 206():71-91. PubMed ID: 12152235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.